MIRM FY 2021 Earnings — Mirum Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

MIRMMirum Pharmaceuticals, Inc.

$5B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$19M

Gross Profit

$17M90.1% margin

Operating Income

-$173M-906.1% margin

Net Income

-$84M-438.9% margin

EPS (Diluted)

$-2.77

Cash Flow

Operating Cash Flow

-$133M

Free Cash Flow

-$152M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$295M

Total Liabilities

$174M

Stockholders' Equity

$120M

Cash & Equivalents

$31M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$0	—
Gross Profit	$17M	-$623,000	+2866.5%
Operating Income	-$173M	-$104M	-66.3%
Net Income	-$84M	-$103M	+18.7%